Hospital Clinic, University of Barcelona, Barcelona (Spain)
0
follower
4
more
presentations
in this session
UNISUS study design: a phase 3 superiority study comparing the efficacy, safety, and tolerability of macitentan 75 mg vs macitentan 10 mg in patients with pulmonary arterial hypertension (PAH)
Change in REVEAL Lite 2 and COMPERA 2.0 risk status in patients with pulmonary arterial hypertension initiating oral treprostinil on dual background therapy: a retrospective chart review
Speaker:
Doctor M. Sketch (Research Triangle Park, US)